輸入代號或公司名稱後按 Enter
1786

科妍

-0.50 (-1.15%)最後更新 2026-09-15
台灣 · 上市 · 生技醫療業
43.0572成交張數17.64本益比1.76股價淨值比4.44%殖利率2026-09-15資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025887年增 +0.4%
毛利率202572.0%最新一期
營業利益率202521.4%最新一期
每股盈餘20252.24年增 -36.2%
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計44.3%40.9%34.2%30.2%26.5%32.4%33.3%28.1%25.8%28.0%
營業毛利(毛損)55.7%59.1%65.8%69.8%73.5%67.6%66.7%71.9%74.2%72.0%
營業毛利(毛損)淨額55.7%59.1%65.8%69.8%73.5%67.6%66.7%71.9%74.2%72.0%
推銷費用13.1%13.9%13.4%17.1%18.0%18.6%19.8%24.8%28.1%28.6%
管理費用17.0%18.0%13.3%12.1%11.3%11.8%13.4%11.6%11.1%11.4%
研究發展費用13.4%15.2%14.6%9.9%12.8%13.0%9.4%7.5%6.9%10.5%
營業費用合計43.5%47.1%41.3%39.1%42.1%43.5%42.6%43.9%46.1%50.6%
營業利益(損失)12.2%12.1%24.5%30.6%31.4%24.1%24.2%28.0%28.1%21.4%
利息收入0.4%0.5%0.9%2.1%2.3%2.8%
其他收入0.8%3.4%3.7%2.8%2.0%0.2%0.0%0.1%0.2%0.0%
其他利益及損失淨額-24.4%-5.1%0.9%-1.3%0.9%-0.3%6.6%0.4%3.1%-2.4%
財務成本淨額2.2%1.6%0.8%1.5%1.6%1.6%1.2%1.2%0.6%0.9%
營業外收入及支出合計-25.8%-3.3%3.8%0.0%1.3%-1.2%7.0%1.5%4.9%-0.6%
稅前淨利(淨損)-13.6%8.8%28.2%30.7%32.7%23.0%31.1%29.5%33.0%20.9%
所得稅費用(利益)合計-2.1%2.1%1.9%3.1%5.2%2.8%5.7%4.5%5.6%2.6%
繼續營業單位本期淨利(淨損)-11.5%6.6%26.4%27.6%27.4%20.1%25.4%25.0%27.4%18.3%
本期淨利(淨損)-11.5%6.6%26.4%27.6%27.4%20.1%25.4%25.0%27.4%18.3%
確定福利計畫之再衡量數-1.1%0.7%-1.5%-0.1%-1.4%0.6%0.7%0.1%0.5%-0.5%
與不重分類之項目相關之所得稅0.0%-0.8%-0.3%-0.0%-0.3%0.1%0.1%0.0%0.1%-0.1%
不重分類至損益之項目:-0.1%-1.1%0.5%0.5%0.1%0.4%-0.4%
國外營運機構財務報表換算之兌換差額0.1%-0.3%-0.0%-0.0%0.0%-0.0%0.0%-0.0%0.0%0.0%
後續可能重分類至損益之項目:-0.0%0.0%-0.0%0.0%-0.0%0.0%0.0%
其他綜合損益(淨額)-1.0%1.2%-1.2%-0.1%-1.1%0.5%0.5%0.1%0.4%-0.4%
本期綜合損益總額-12.5%7.8%25.2%27.5%26.3%20.6%26.0%25.0%27.9%17.9%
母公司業主(淨利∕損)-11.5%6.6%26.4%27.6%27.4%20.1%25.4%25.0%27.4%18.3%
母公司業主(綜合損益)-12.5%7.8%25.2%27.5%26.3%20.6%26.0%25.0%27.9%17.9%
基本每股盈餘-0.2%0.1%0.5%0.5%0.4%0.3%0.4%0.4%0.4%0.3%
稀釋每股盈餘-0.2%0.1%0.5%0.5%0.4%0.3%0.3%0.3%0.4%0.2%
除列按攤銷後成本衡量金融資產淨損益-0.4%-0.0%0.7%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。